Document is current
Any future updates will be listed below
-
Authors
Tang, Walfred W. C. https://orcid.org/0000-0002-5803-1681
Castillo-Venzor, Aracely https://orcid.org/0000-0002-2288-2679
Gruhn, Wolfram H. https://orcid.org/0000-0001-6072-1916
Kobayashi, Toshihiro
Penfold, Christopher A.
Morgan, Michael D.
Sun, Dawei
Irie, Naoko
Surani, M. Azim https://orcid.org/0000-0002-8640-4318
-
Funding
Funding for this research was provided by:
Wellcome Trust (209475/Z/17/Z, 203831/Z/16/Z)
RCUK | Medical Research Council (RG85305, RG85305)
RCUK | Biotechnology and Biological Sciences Research Council (G103986, G103986)
Croucher Foundation
Isaac Newton Trust
Astellas Foundation for Research on Metabolic Disorders
- License Information
-
More Information
Article History
Received: 8 October 2020
Accepted: 28 February 2022
First Online: 11 April 2022
Competing interests
: W.W.C.T. is currently employed by Adrestia Therapeutics Ltd. The other authors declare no competing interests.
